ESTRO 2021 Abstract Book

S1249

ESTRO 2021

Figure I. Hypofractionated treatments per year Figure II shows percentage of curative treatments per pathology and year. There was an increase of breast treatments in 2020 (37%) in comparison with 2018 (28%) and 2019 (32%). On the other hand, there was a slightly reduction of prostate treatments: 23% in 2019 and 20% in 2020. Percentage of treatments for the rest of pathologies was similar to previous years.

Figure II. Curative treatments per pathology and year

Conclusion On one side, reasons related directly or indirectly with COVID-19 do not had an effect on the treatment intent in our department: similar number of palliative treatments was reported during 2020. On the other side, the use of hypofractionated schemes was accelerated during the pandemic, following national and international recommendations. This has allowed reducing treatment time bringing more comfort to the patients. To resume, it is difficult to assess whether the pandemic had a negative effect on cancer treatments based on treatment intent. Deeper analysis of cancer staging could reveal a different result related to collateral damage to the pandemic. PO-1525 Does online learning in delineation thrive during a Pandemic? The FALCON group experience. C. Valentini 1 , J. Cacicedo 2 , J. Luis 3 , E. Arrojo 4 , V. Lancellotta 5 , A. Matias 6 , B. Tamaskovics 7 , M. Palmu 8 , E. Rivin del Campo 9 1 Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Dresden, Germany; 2 Cruces University Hospital, Osakidetza/Biocruces Health Research Institute/Department of Surgery, Radiology and Physical Medicine of the University of the Basque Country (UPV/EHU), Radiation Oncology Department, Barakaldo, Spain; 3 Hospital Universitario Virgen del Rocío, Oncología Radioterápica, Sivilla, Spain; 4 INMOA - Medical institute of advanced oncology, Radiotherapy Oncology, Madrid, Spain; 5 Fondazione Policlinico Universitario A. Gemelli IRCCS, U.O.C. Radioterapia Oncologica, Dipartimento di Diagnostica per immagini, Radioterapia Oncologica ed Ematologia, Rome, Italy; 6 Complejo Asistencial Universitario de Salamanca, España, Radiation Oncology, Salamanca, Spain; 7 Heinrich Heine University, Radiation Oncology, Duesseldorf, Germany; 8 ESTRO, European SocieTy for Radiotherapy and Oncology, Senior Project Manager Education, Bruxelles, Belgium; 9 Tenon University Hospital, Sorbonne University, Radiation Oncology, Paris, France Purpose or Objective The Pandemic outbreak required an adaptation of how continuing medical education could be carried out, nolonger on site.